CBST/CXA-201 hits primary endpoint in phase III in cUTI http://www.cubist.com/news/115-cubist_announces_positive_top-line_results_from_phase_3_trial_of_investigational_antibiotic_ceftolozane_tazobactam_in_complicated_urinary_tract_infections